Chris Verslype

Research interests

Publications

• Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(23)00727-4

• The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

  ESMO Open · 2023 · https://doi.org/10.1016/j.esmoop.2023.101567

• Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma

  Gastroenterology · 2022 · https://doi.org/10.1053/j.gastro.2022.09.005

• Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

  Annals of Oncology · 2021 · 10.1016/j.annonc.2021.02.014

• Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

  Annals of Oncology · 2019 · 10.1093/annonc/mdy510

• Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity

  Nature · 2019 · https://doi.org/10.1038/s41586-019-0904-1

• Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

  Journal of Hepatology · 2019 · 10.1016/j.jhep.2019.08.006

• Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy308

• Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

  The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30351-6

• Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

  Gut · 2018 · https://doi.org/10.1136/gutjnl-2018-316408

• Keratin 19: a key role player in the invasion of human hepatocellular carcinomas

  Gut · 2013 · 10.1136/gutjnl-2012-304351

• Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes

  Hepatology · 2012 · 10.1002/hep.25595

• Hepatocellular carcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2012 · 10.1093/annonc/mds225

• Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.28.5643

• Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study

  Gut · 2010 · 10.1136/gut.2009.189639

• Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

  Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.20.0238

• Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin

  Hepatology · 2008 · 10.1002/hep.22238

• Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2007.13.2183

• Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study

  The Lancet Oncology · 2007 · 10.1016/s1470-2045(07)70108-0

• Glypican-3 Expression Distinguishes Small Hepatocellular Carcinomas From Cirrhosis, Dysplastic Nodules, and Focal Nodular Hyperplasia-like Nodules

  The American Journal of Surgical Pathology · 2006 · 10.1097/01.pas.0000213323.97294.9a

• Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure

  Critical Care · 2006 · 10.1186/cc4985

• The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin

  Histopathology · 2006 · 10.1111/j.1365-2559.2006.02468.x

• Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

  Journal of Clinical Oncology · 2004 · https://doi.org/10.1200/jco.2004.10.112

• Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

  New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa033025

• Oxidative Stress and Oval Cell Accumulation in Mice and Humans with Alcoholic and Nonalcoholic Fatty Liver Disease

  American Journal Of Pathology · 2003 · 10.1016/s0002-9440(10)63489-x

Current projects

No projects listed.